European Journal of Cancer

149 Periodical Search Results
You searched for "visceral" AND "metastases" OR "neoplasm metastasis" OR "neoplasm, metastatic" OR "secondary malignant neoplastic disease" within European Journal of Cancer
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert
Viewing 1-20 of 149 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >

Display:

	Fulvestrant (Faslodex™) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials L. Mauriac, J.E. Pippen, J. Quaresma Albano, S.Z. Gertler, C.K. Osborne European Journal of Cancer June 2003 (Vol. 39, Issue 9, Pages 1228-1233) Abstract \| Full Text \| Full-Text PDF (196 KB)
	Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report M Marchand, C.J.A Punt, S Aamdal, B Escudier, W.H.J Kruit, U Keilholz, L Håkansson, N van Baren, Y Humblet, P Mulders, M.-F Avril, A.M.M Eggermont, C Scheibenbogen, J Uiters, J Wanders, M Delire, T Boon, G Stoter European Journal of Cancer January 2003 (Vol. 39, Issue 1, Pages 70-77) Abstract \| Full Text \| Full-Text PDF (283 KB)
	Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience G.G. Steger, R. Bartsch, C. Wenzel, U. Pluschnig, D. Hussian, U. Sevelda, G.J. Locker, M.F. Gnant, R. Jakesz, C.C. Zielinski European Journal of Cancer November 2005 (Vol. 41, Issue 17, Pages 2655-2661) Abstract \| Full Text \| Full-Text PDF (139 KB)
	Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer J.A Kramer, D Curran, M Piccart, J.C.J.M de Haes, P Bruning, J Klijn, I Van Hoorebeeck, R Paridaens European Journal of Cancer August 2000 (Vol. 36, Issue 12, Pages 1498-1506) Abstract \| Full Text \| Full-Text PDF (126 KB)
	Combination of taxanes and anthracyclines in first-line chemotherapy of metastatic breast cancer: an interim report K. Friedrichs, F. Hölzel, F. Jänicke European Journal of Cancer September 2002 (Vol. 38, Issue 13, Pages 1730-1738) Abstract \| Full Text \| Full-Text PDF (129 KB)
	Estimates of the lifetime costs of breast cancer treatment in Canada B.P. Will, J.-M. Berthelot, C. Le Petit, E.M. Tomiak, S. Verma, W.K. Evans European Journal of Cancer April 2000 (Vol. 36, Issue 6, Pages 724-735) Abstract \| Full Text \| Full-Text PDF (251 KB)
	Testing a new staging system for cutaneous melanoma proposed by the American Joint Committee on Cancer S Merkel, T Meyer, T Papadopoulos, G Schuler, J Göhl, W Hohenberger, P Hermanek European Journal of Cancer March 2002 (Vol. 38, Issue 4, Pages 517-526) Abstract \| Full Text \| Full-Text PDF (494 KB)
	Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature R.M. Bremnes, J.M. Kvamme, H. Stalsberg, E.A. Jacobsen European Journal of Cancer March 1999 (Vol. 35, Issue 3, Pages 433-437) Abstract \| Full Text \| Full-Text PDF (783 KB)
	Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine A Seeber, M Binder, A Steiner, K Wolff, H Pehamberger European Journal of Cancer December 1998 (Vol. 34, Issue 13, Pages 2129-2131) Abstract \| Full Text \| Full-Text PDF (60 KB)
	Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer J. Bellmunt, V. Guillem, L. Paz-Ares, J.L. González-Larriba, J. Carles, J. Albanell, J.M. Tabernero, H. Cortés-Funes, J. Baselga European Journal of Cancer July 2000 (Vol. 36Supplement 2, Pages 17-25) Abstract \| Full Text \| Full-Text PDF (118 KB)
	Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy M Castiglione-Gertsch, M Tattersall, A Hacking, A Goldhirsch, A Gudgeon, R.D Gelber, J Lindtner, A Coates, J Collins, M Isley, H.-J Senn, C.-M Rudenstam, the International Breast Cancer Study Group European Journal of Cancer December 1997 (Vol. 33, Issue 14, Pages 2321-2325) Abstract \| Full Text \| Full-Text PDF (99 KB)
	Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials G Atalay, L Biganzoli, F Renard, R Paridaens, T Cufer, R Coleman, A.H Calvert, T Gamucci, A Minisini, P Therasse, M.J Piccart, on behalf of the EORTC Breast Cancer and Early Clinical Studies Groups European Journal of Cancer November 2003 (Vol. 39, Issue 17, Pages 2439-2449) Abstract \| Full Text \| Full-Text PDF (229 KB)
	Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients Léonie H.M. Smit, Catharina M. Korse, Augustinus A.M. Hart, Johannes M.G. Bonfrer, John B.A.G. Haanen, J. Martijn Kerst, Omgo E. Nieweg, Gijsbert C. de Gast European Journal of Cancer February 2005 (Vol. 41, Issue 3, Pages 386-392) Abstract \| Full Text \| Full-Text PDF (189 KB)
	Chemotherapy in patients with castration-resistant prostate cancer Hielke J. Meulenbeld, Paul Hamberg, Ronald de Wit European Journal of Cancer September 2009 (Vol. 45Supplement 1, Pages 161-171) Full Text \| Full-Text PDF (344 KB)
	Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy? , 18 May 2009 R.E. Coleman European Journal of Cancer July 2009 (Vol. 45, Issue 11, Pages 1909-1915) Abstract \| Full Text \| Full-Text PDF (301 KB)
	c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease A Jukkola, R Bloigu, Y Soini, E.-R Savolainen, K Holli, G Blanco European Journal of Cancer February 2001 (Vol. 37, Issue 3, Pages 347-354) Abstract \| Full Text \| Full-Text PDF (135 KB)
	Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women B. Thürlimann, J.F.R. Robertson, J.M. Nabholtz, A. Buzdar, J. Bonneterre, on behalf of the Arimidex Study Group. European Journal of Cancer November 2003 (Vol. 39, Issue 16, Pages 2310-2317) Abstract \| Full Text \| Full-Text PDF (247 KB)
	High positive sentinel node identification rate by EORTC melanoma group protocol: Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma A.C.J. van Akkooi, J.H.W. de Wilt, C. Verhoef, W.J. Graveland, A.N. van Geel, M. Kliffen, A.M.M. Eggermont European Journal of Cancer February 2006 (Vol. 42, Issue 3, Pages 372-380) Abstract \| Full Text \| Full-Text PDF (176 KB)
	Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours C.N. Sternberg, P. de Mulder, J.H. Schornagel, C. Theodore, S.D. Fossa, A.T. van Oosterom, J.A. Witjes, M. Spina, C.J. van Groeningen, B. Duclos, J.T. Roberts, C. de Balincourt, L. Collette, the EORTC Genito-Urinary Cancer Group European Journal of Cancer January 2006 (Vol. 42, Issue 1, Pages 50-54) Abstract \| Full Text \| Full-Text PDF (135 KB)
	Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support C. Kollmannsberger, N. Schleucher, O. Rick, B. Metzner, J.T. Hartmann, P. Schöffski, J. Beyer, J. Casper, M. Sosada, H.-J. Schmoll, I. Böhlke, C. Meisner, L. Kanz, C. Bokemeyer European Journal of Cancer April 2003 (Vol. 39, Issue 6, Pages 775-782) Abstract \| Full Text \| Full-Text PDF (169 KB)

Display:

Viewing 1-20 of 149 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert